Publications by authors named "Gregory Yanik"

99Publications

Response to Maccio et al., "Multifactorial Pathogenesis of COVID-19-related Coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?"

J Thromb Haemost 2020 Aug 28. Epub 2020 Aug 28.

Department of Hematology, Stem Cell Transplant and Cell Therapy Unit, IMIB-Arrixaca, Virgen de la Arrixaca University Hospital, University of Murcia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jth.15088DOI Listing
August 2020

A model for in situ plan of care for a critically unstable pediatric patient following I-131 MIBG infusion.

Pediatr Blood Cancer 2020 Aug 22:e28665. Epub 2020 Aug 22.

Department of Pediatrics - Hematology/Oncology, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.28665DOI Listing
August 2020

Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.

Biol Blood Marrow Transplant 2020 May 5;26(5):e94-e100. Epub 2020 Feb 5.

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.01.024DOI Listing
May 2020

How Should We Determine the Value of CAR T-Cell Therapy?

AMA J Ethics 2019 10 1;21(10):E844-851. Epub 2019 Oct 1.

An assistant professor in the Department of Otolaryngology-Head and Neck Surgery and the co-chief of the clinical ethics service in the Center for Bioethics and Social Sciences in Medicine at the University of Michigan Medical School in Ann Arbor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/amajethics.2019.844DOI Listing
October 2019

Respiratory Tract Colonization by species Portends Worse Outcomes in Immunocompromised Patients.

Clin Pulm Med 2018 Nov;25(6):197-201

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical School, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00045413-201811000-0000
Publisher Site
http://dx.doi.org/10.1097/CPM.0000000000000279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430131PMC
November 2018

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Biol Blood Marrow Transplant 2019 04 10;25(4):699-711. Epub 2018 Nov 10.

Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota; National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.11.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453753PMC
April 2019

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Haematologica 2019 04 31;104(4):844-854. Epub 2018 Oct 31.

Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.200121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442962PMC
April 2019

Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.

Bone Marrow Transplant 2020 03 4;55(3):531-537. Epub 2018 Sep 4.

Department of Pediatrics, University of California San Francisco Benioff Children's Hospital, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0298-y
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0298-yDOI Listing
March 2020

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

N Engl J Med 2018 02;378(5):439-448

From the Departments of Pediatrics (S.L.M., S.A.G.) and Pathology and Laboratory Medicine (C.H.J., B.L.L.), Perelman School of Medicine, and Abramson Cancer Center (C.H.J., B.L.L.), University of Pennsylvania, and the Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia (S.L.M., S.A.G.) - all in Philadelphia; the Department of Pediatrics and Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, and the Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas (T.W.L.); the Department of Pediatric Hematology and Oncology, Oslo University Hospital, Oslo (J.B.); the Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Deu Barcelona, Barcelona (S.R.); the Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City (M.B.); the Department of Pediatrics, Faculty of Medicine, University of Montreal, and the Hematology Oncology Division and Charles-Bruneau Cancer Center, Centre Hospitalier Universitaire Sainte-Justine Research Center, Montreal (H.B.), and the Division of Haematology/Oncology/Bone Marrow Transplantation, Hospital for Sick Children, Toronto (J.K.) - all in Canada; the Division of Stem Cell Transplantation and Immunology, Hospital for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany (P.B.); the Division of Pediatric Blood and Marrow Transplant, University of Minnesota, Minneapolis (M.R.V., H.E.S.); Children's Mercy Hospital and Clinics, Kansas City, MO (G.D.M.); Aflac Cancer and Blood Disorders Center, Emory University, Atlanta (M.Q.); the Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, and the Cancer Research Institute Ghent (CRIG), Ghent, Belgium (B.D.M.); the Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto, Japan (H.H.); the Department of Pediatrics, Stanford University School of Medicine, Stanford (K. Schlis, K.L.D.), and the Division of Hematology, Oncology, Blood and Marrow Transplant, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles (M.A.P.) - all in California; the Division of Pediatric Blood and Marrow Transplant, Duke University Medical Center, Durham, NC (P.L.M.); Oregon Health and Science University, Portland (E.R.N.); C.S. Mott Children's Hospital, Ann Arbor, MI (G.A.Y.); the Stem Cell Transplantation Unit, St. Anna Children's Hospital, Vienna (C.P.); University Hospital Robert Debré and University Paris Diderot (A. Baruchel), and Saint-Louis Hospital and University Paris Diderot (N.B.), Paris; the Royal Children's Hospital, Melbourne, VIC, Australia (F.M.); Clinica Pediatrica Universita degli Studi di Milano Bicocca, Monza, Italy (A. Balduzzi); and Novartis Pharmaceuticals (P.W., T.T., M.L., Y.Z., K. Sen, D.L.) and Novartis Institutes for Biomedical Research (K.T.M.) - both in East Hanover, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1709866DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996391PMC
February 2018

An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.

Pediatr Blood Cancer 2018 Jan 12;65(1). Epub 2017 Aug 12.

Division of Pediatric Hematology Oncology, University of Michigan Medical Center, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26758DOI Listing
January 2018

Phase I study of bortezomib in combination with irinotecan in patients with relapsed/refractory high-risk neuroblastoma.

Pediatr Blood Cancer 2017 Nov 24;64(11). Epub 2017 Apr 24.

Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26563DOI Listing
November 2017

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2017 Mar 22;23(3):522-528. Epub 2016 Dec 22.

Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan; Division of Pediatric Infectious Disease, University of Michigan, Ann Arbor, Michigan; Blood and Marrow Transplant Program, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.12.630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551893PMC
March 2017

Review at a multidisciplinary tumor board impacts critical management decisions of pediatric patients with cancer.

Pediatr Blood Cancer 2017 02 31;64(2):254-258. Epub 2016 Aug 31.

Department of Surgery, Section of Pediatric Surgery, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26201DOI Listing
February 2017

Procedure-related complications and adverse events associated with pediatric autologous peripheral blood stem cell collection.

J Clin Apher 2017 Feb 19;32(1):35-48. Epub 2016 Apr 19.

Department of Pediatric Bone Marrow Transplantation, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jca.21465DOI Listing
February 2017

¹³¹I-Metaiodobenzylguanidine Theranostics in Neuroblastoma: Historical Perspectives; Practical Applications.

Semin Nucl Med 2016 May;46(3):184-202

Department of Pediatrics, University of Michigan Medical Center, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2016.02.002DOI Listing
May 2016

Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.

Biol Blood Marrow Transplant 2016 May 6;22(5):862-8. Epub 2015 Nov 6.

Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan; Blood and Marrow Transplant Program, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839477PMC
May 2016

Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.

Pediatr Blood Cancer 2016 Jan 8;63(1):164-7. Epub 2015 Aug 8.

Division of Pediatric Hematology and Oncology, Department of Pediatrics and Communicable Diseases, University of Michigan Medical Center, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25702DOI Listing
January 2016

Different outcomes for relapsed versus refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG).

Eur J Cancer 2015 Nov 5;51(16):2465-72. Epub 2015 Aug 5.

Department of Pediatrics, University of California San Francisco School of Medicine and UCSF Benioff Children's Hospital, San Francisco, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.07.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607645PMC
November 2015

Variation in Management of Fever and Neutropenia Among Pediatric Patients With Cancer: A Survey of Providers in Michigan.

Pediatr Hematol Oncol 2015 18;32(5):331-40. Epub 2015 Jun 18.

Section of Pediatric Hematology Oncology, Department of Pediatrics, Indiana University , Indianapolis, Indiana , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08880018.2015.1036331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807353PMC
May 2016

Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.

Biol Blood Marrow Transplant 2015 Jun 14;21(6):1127-31. Epub 2015 Feb 14.

Blood and Marrow Transplant Program, University of Michigan Health System, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970454PMC
June 2015

Transforming growth factor-β induces microRNA-29b to promote murine alveolar macrophage dysfunction after bone marrow transplantation.

Am J Physiol Lung Cell Mol Physiol 2015 Jan 31;308(1):L86-95. Epub 2014 Oct 31.

Graduate Program in Immunology, University of Michigan Medical School, Ann Arbor, Michigan; Pulmonary and Critical Care Medicine Division, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan; Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajplung.00283.2014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281703PMC
January 2015

Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2014 Oct 18;20(10):1592-8. Epub 2014 Jun 18.

Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan; Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, Michigan; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.06.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163140PMC
October 2014

Management of noninfectious lung injury following hematopoietic cell transplantation.

Curr Opin Oncol 2013 Mar;25(2):187-94

Division of Hematology and Oncology, Blood and Marrow Transplant Program, University of Michigan Medical Center, Ann Arbor, Michigan 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32835dc8a5DOI Listing
March 2013

Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.

Semin Nucl Med 2012 May;42(3):171-84

Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, MI 48103-5028, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semnuclmed.2011.11.004DOI Listing
May 2012

Neuroblastoma: issues in transplantation.

Biol Blood Marrow Transplant 2012 Jan;18(1 Suppl):S92-100

Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.10.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260463PMC
January 2012

Soluble tumor necrosis factor receptor: enbrel (etanercept) for subacute pulmonary dysfunction following allogeneic stem cell transplantation.

Biol Blood Marrow Transplant 2012 Jul 10;18(7):1044-54. Epub 2011 Dec 10.

Blood and Marrow Stem Cell Transplantation Program, Division of Hematology/Oncology, Department of Pediatrics, University of Michigan Medical Center,1500 E.Medical Center Drive, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.11.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462521PMC
July 2012

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study.

Cancer Chemother Pharmacol 2011 Oct 22;68(4):1057-65. Epub 2011 Feb 22.

Department of Pediatrics and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1581-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238911PMC
October 2011

Bortezomib as a therapeutic candidate for neuroblastoma.

J Exp Ther Oncol 2008 ;7(2):135-45

Department of Pediatrics, Division of Pediatric Hematology-Oncology, The University of Michigan Medical School, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
January 2009

Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.

Eur J Nucl Med Mol Imaging 2008 Nov 6;35(11):2105-12. Epub 2008 Aug 6.

Department of Radiology, Nuclear Medicine Division, University of Michigan, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-008-0873-3DOI Listing
November 2008

Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.

Pediatr Blood Cancer 2008 Apr;50(4):917-9

Department of Pediatrics, Division of Pediatric Hematology-Oncology and Blood and Marrow Transplantation, University of Michigan Health System, Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://deepblue.lib.umich.edu/bitstream/handle/2027.42/58036
Web Search
http://doi.wiley.com/10.1002/pbc.21187
Publisher Site
http://dx.doi.org/10.1002/pbc.21187DOI Listing
April 2008

The lung as a target organ of graft-versus-host disease.

Semin Hematol 2006 Jan;43(1):42-52

Department of Pediatrics, Division of Hematology/Oncology, Blood and Marrow Transplantation Program, University of Michigan Cancer Center, Ann Arbor, MI 48109-0942, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2005.09.004DOI Listing
January 2006

Radiation-induced osteosarcoma and papillary carcinoma of the thyroid.

Clin Nucl Med 2006 Jan;31(1):5-8

Department of South Coast Radiology, Mermaid Beach, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.rlu.0000190891.59706.4dDOI Listing
January 2006

Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.

Clin Adv Hematol Oncol 2005 May;3(5):415-9, 428

University of Michigan Medical School, 1500 E. Medical Center Drive, 6308 CCGC, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
May 2005

Utility of cranial boost in addition to total body irradiation in the treatment of high risk acute lymphoblastic leukemia.

Int J Radiat Oncol Biol Phys 2005 Nov 22;63(4):1191-6. Epub 2005 Jun 22.

Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109-0010, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S036030160500706
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2005.04.020DOI Listing
November 2005

CT of renal lymphoma in children.

AJR Am J Roentgenol 2003 Feb;180(2):429-31

Section of Pediatric Radiology, C.S. Mott Children's Hospital, University of Michigan Medical Center, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0252, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/ajr.180.2.1800429DOI Listing
February 2003

Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.

Biol Blood Marrow Transplant 2002 ;8(7):395-400

Department of Pediatrics, University of Michigan Cancer Center and Mott Children's Hospital, Ann Arbor 48109-0942, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/bbmt.2002.v8.pm12171486DOI Listing
July 2003

Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.

J Clin Oncol 2002 Apr;20(8):2142-9

Blood and Marrow Stem Cell Transplantation Program, Division of Pediatric Hematology-Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.08.124DOI Listing
April 2002